Dongzhimen Hospital, Beijing
Clinical trials sponsored by Dongzhimen Hospital, Beijing, explained in plain language.
-
Herbal capsule may slow brain vessel damage in hypertensive patients
Disease control Not yet recruitingThis study tests whether Songling Xuemaikang capsules can help control cerebral small vessel disease (CSVD), a condition where small blood vessels in the brain get damaged over time, often linked to high blood pressure. Researchers will enroll 90 adults aged 55-75 with hypertensi…
Phase: NA • Sponsor: Dongzhimen Hospital, Beijing • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a traditional chinese herbal granule boost stroke recovery?
Disease control Not yet recruitingThis study tests a traditional Chinese herbal medicine called Xinglou Chengqi Granule for people who recently had a stroke. Researchers want to find the best dose and see if it helps improve recovery. Sixty adults aged 18-70 with moderate stroke symptoms will receive either a hig…
Phase: PHASE2 • Sponsor: Dongzhimen Hospital, Beijing • Aim: Disease control
Last updated Jun 26, 2026 15:11 UTC